Immutep Ltd ADR (IMMP) Stock Analysis

Immutep Ltd ADR (IMMP) is a publicly traded company in the HEALTHCARE sector. It trades at $0.42, carries a market capitalization of $58.59M. This page summarizes the public market data, fundamentals, and frequently asked questions for IMMP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.42
• Market Cap: $58.59M
• EPS: $-0.38
• 52-Week High: $3.32
• 52-Week Low: $0.29

Market Sentiment

Immutep Ltd ADR currently has a Bearish sentiment score of -0.39.

About Immutep Ltd ADR

Immutep Ltd ADR is a biotechnology company headquartered in Sydney, Australia, specializing in the development of innovative immunotherapy treatments for cancer and autoimmune diseases. The firm is advancing its lead product candidates designed to modulate immune responses, thereby enhancing the body's capacity to combat tumors. With a promising pipeline and established strategic partnerships, Immutep aims to transform therapeutic approaches in oncology, positioning itself to capitalize on su...

GNG Research Analysis

GNG Research scores Immutep Ltd ADR (IMMP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IMMP.

Frequently Asked Questions

Does IMMP pay dividends?

Immutep Ltd ADR (IMMP) does not currently pay a regular dividend.

What is IMMP's market cap?

Immutep Ltd ADR (IMMP) has a market capitalization of $58.59M with a current stock price of $0.42.